PG 01037 dihydrochloride |
| Catalog No.GC11810 |
PG01037(이염산염)은 Ki가 0.7nM인 강력하고 선택적인 도파민 D3 수용체 길항제입니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 675599-62-9
Sample solution is provided at 25 µL, 10mM.
GlpBio Products Cited In Reputable Papers
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
| Cas No. | 675599-62-9 | SDF | |
| Chemical Name | (E)-N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)but-2-en-1-yl)-4-(pyridin-2-yl)benzamide dihydrochloride | ||
| Canonical SMILES | ClC1=C(Cl)C(N2CCN(CC2)C/C([H])=C([H])/CNC(C3=CC=C(C4=CC=CC=N4)C=C3)=O)=CC=C1.Cl.Cl | ||
| Formula | C26H26Cl2N4O.2HCl | M.Wt | 554.34 |
| Solubility | DMF: 5 mg/mL,DMSO: 30 mg/mL,Ethanol: 2 mg/mL | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 1.8039 mL | 9.0197 mL | 18.0395 mL |
| 5 mM | 0.3608 mL | 1.8039 mL | 3.6079 mL |
| 10 mM | 0.1804 mL | 0.902 mL | 1.8039 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC16377 SRT3190
- GC35616 Cauloside C
- GC30212 (S)-Willardiine ((-)-Willardiine)
- GC31695 Acrivastine (BW825C)
- GC16628 Chlorothricin
- GC41196 (±)16-HDHA
- GC17834 Teijin compound 1
- GC45451 Estrone 3-methyl ether
- GC44316 Naphyrone 1-naphthyl isomer (hydrochloride)
- GC33949 4-Chlorosalicylic acid
- GC17290 Balofloxacin
- GC39233 Butyl isobutyl phthalate
- GC33652 MRS1177
- GC18295 Fluralaner
- GC36129 Gemcabene calcium
- GC42305 3-Methylbuphedrone (hydrochloride)
- GC32470 Coenzyme Q9 (Ubiquinone Q9)
리뷰
Average Rating: 5 ★★★★★ (Based on Reviews and 26 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *